STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Charlie's Holdings (OTCQB: CHUC) Begins SBX Roll-Out and Reports 336% Growth to $7.1 Million Revenue for Q3 2025

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

Charlie's Holdings (OTCQB: CHUC) reported Q3 2025 revenue of $7.1 million, a 336% increase versus Q3 2024, and returned to profitability with net income of $0.6 million versus a $1.0 million loss a year earlier. Gross profit was $1.8 million (24.9% margin). The company said SBX rollout began in seven states and now represents the majority of sales. Charlie's completed a $1.0 million PMTA asset sale in August, bringing PMTA-related proceeds to $7.5 million with $4.2 million contingent. Cash was $1.1 million and total assets $10.6 million. Management expects continued growth and a US filling line opening in Q4 2025.

Charlie's Holdings (OTCQB: CHUC) ha riportato un fatturato del terzo trimestre 2025 di 7,1 milioni di dollari, un incremento del 336% rispetto al terzo trimestre 2024, e tornata in utile con un reddito netto di 0,6 milioni di dollari contro una perdita di 1,0 milione l'anno precedente. Il margine di utile lordo è stato del 24,9% con un profitto lordo di 1,8 milioni di dollari. L'azienda ha dichiarato che la rollout di SBX è iniziata in sette stati e ora rappresenta la maggioranza delle vendite. Charlie's ha completato una vendita di asset PMTA per 1,0 milione di dollari in agosto, portando i proventi legati al PMTA a 7,5 milioni con 4,2 milioni contingent. La cassa era di 1,1 milioni e gli attivi totali di 10,6 milioni. La direzione si aspetta una crescita continua e l'apertura di una linea di riempimento negli Stati Uniti nel quarto trimestre 2025.

Charlie's Holdings (OTCQB: CHUC) informó ingreso del tercer trimestre de 2025 de 7,1 millones de dólares, un aumento del 336% frente al tercer trimestre de 2024, y volvió a ser rentable con ingreso neto de 0,6 millones de dólares frente a una pérdida de 1,0 millón del año anterior. La ganancia bruta fue de 1,8 millones de dólares (margen del 24,9%). La compañía indicó que la implementación de SBX comenzó en siete estados y ahora representa la mayoría de las ventas. Charlie's completó una venta de activos PMTA por 1,0 millón de dólares en agosto, llevando los ingresos relacionados con PMTA a 7,5 millones, con 4,2 millones contingentes. El efectivo era de 1,1 millones y los activos totales de 10,6 millones. la gerencia espera un crecimiento continuo y la apertura de una línea de llenado en EE. UU. en el cuarto trimestre de 2025.

Charlie's Holdings (OTCQB: CHUC)2025년 3분기 매출 710만 달러를 보고했고, 2024년 3분기 대비 336% 증가했으며, 순이익 60만 달러로 흑자전환에 성공했습니다. 총이익은 180만 달러(마진 24.9%)였습니다. 회사는 SBX 롤아웃이 7개 주에서 시작되어 현재 매출의 대다수를 차지한다고 밝혔습니다. Charlie's는 8월에 PMTA 자산 매각 100만 달러를 완료했고, PMTA 관련 수익은 750만 달러에 이르고 420만 달러는 조건부로 남아 있습니다. 현금은 110만 달러, 총자산은 1060만 달러였습니다. 경영진은 지속적인 성장을 예상하며 2025년 4분기에 미국 내 충전라인 개통을 기대하고 있습니다.

Charlie's Holdings (OTCQB: CHUC) a annoncé un chiffre d'affaires du troisième trimestre 2025 de 7,1 millions de dollars, en hausse de 336% par rapport au T3 2024, et est revenu à la rentabilité avec un résultat net de 0,6 million de dollars contre une perte de 1,0 million l'année précédente. Le bénéfice brut était de 1,8 million de dollars (marge de 24,9%). L'entreprise a indiqué que le déploiement du SBX avait débuté dans sept États et représente désormais la majorité des ventes. Charlie's a complété une vente d'actifs PMTA pour 1,0 million de dollars en août, portant les produits liés au PMTA à 7,5 millions, avec 4,2 millions conditionnels. La trésorerie était de 1,1 million et les actifs totaux de 10,6 millions. La direction prévoit une croissance continue et l'ouverture d'une ligne de remplissage américaine au cours du T4 2025.

Charlie's Holdings (OTCQB: CHUC) meldete einen Umsatz im dritten Quartal 2025 von 7,1 Mio. USD, eine Steigerung von 336% gegenüber Q3 2024, und kehrte in die Rentabilität zurück mit einem Nettogewinn von 0,6 Mio. USD gegenüber einem Verlust von 1,0 Mio. USD im Vorjahr. Der Bruttogewinn betrug 1,8 Mio. USD (Marge 24,9%). Das Unternehmen sagte, dass der SBX-Rollout in sieben Bundesstaaten begann und nun den Großteil der Verkäufe ausmacht. Charlie's schloss im August eine PMTA-Asset-Verkauf über 1,0 Mio. USD ab, wodurch PMTA-bezogene Erlöse auf 7,5 Mio. USD anstiegen, davon 4,2 Mio. USD bedingt. Die Zahlungsmittel beliefen sich auf 1,1 Mio. USD und die Gesamtaktiva betrugen 10,6 Mio. USD. Das Management erwartet weiteres Wachstum und die Eröffnung einer US-Fülllinie im Q4 2025.

Charlie's Holdings (OTCQB: CHUC) أبلغت عن إيرادات الربع الثالث 2025 بقيمة 7.1 مليون دولار، بزيادة قدرها 336% مقارنةً بالربع الثالث من 2024، وعادت إلى الربحية بــ صافي دخل 0.6 مليون دولار مقابل خسارة قدرها 1.0 مليون قبل عام. بلغ إجمالي الربح 1.8 مليون دولار (هامش 24.9%). قالت الشركة إن طرح SBX بدأ في سبع ولايات ويُمثّل الآن غالبية المبيعات. أكملت Charlie's بيع أصول PMTA بقيمة 1.0 مليون دولار في أغسطس، ليصل العائدات المرتبطة بـ PMTA إلى 7.5 مليون دولار مع 4.2 مليون دولار معلق. النقد 1.1 مليون دولار والأصول الكلية 10.6 مليون دولار. تتوقع الإدارة نموًا مستمرًا وافتتاح خط تعبئة أمريكي في الربع الرابع من 2025.

Positive
  • Revenue +336% to $7.1 million in Q3 2025
  • Net income $0.6M vs a $1.0M loss in Q3 2024
  • PMTA proceeds $7.5M to date and $1.0M asset sale in Aug 2025
  • SBX majority sales after Phase I roll-out in 7 states
Negative
  • Gross margin declined to 24.9% from 38.8% (Q3 2024)
  • Total operating expenses increased 40% year-over-year
  • Dependency on a $2M credit facility from a board member to fund growth

$1.0 Million Sale of one PACHA SKU ̶ to a Strategic Buyer ̶ Represents Additional Income Over and Above the Company's $7.1 Million Ordinary Revenue.

Company Projects Continued Strong Growth and an All-Time Revenue Record in Q4

COSTA MESA, CA / ACCESS Newswire / November 19, 2025 / Charlie's Holdings, Inc. (OTCQB:CHUC) ("Charlie's" or the "Company"), an industry leader in the premium vapor products space, today reported results for the three months ended September 30, 2025, and provided an update on recent business highlights.

Key Financial Highlights for Q3 2025 (compared with Q3 2024)

  • Revenue increased 336% to $7.1 million

  • Net income of $0.6 million, from a loss of $1.0 million

  • Cash balance of $1.1 million, compared to $0.2 million

  • Total assets of $10.6 million, compared to $3.9 million

  • Total shareholders' equity of $3.2 million, compared to a deficit of ($1.8) million

Key Balance Sheet Highlights for Q3 2025 (compared with Q4 2024)

Recent Business Highlights

  • Successful SBX introduction in 7 strategically advantaged states; Phase I roll-out began in Q3; Phase II roll-out for multiple regional convenience store chains and distributors will continue in Q4 2025. SBX now represents the majority of the Company's sales.

  • On August 8, 2025, the Company entered into and closed a PMTA asset sale for one PACHA synthetic product and related asset, bringing the total PMTA Products purchased by the strategic Buyer to sixteen. The purchase price for this latest PMTA asset was $1.0 million paid at closing. Accordingly, PMTA Products Strategic Partnerships have now generated $7.5 million in income with an additional $4.2 million in contingent payments possible over the next 12 months.

  • On August 26, 2025, the Company announced that, in order to facilitate increased SBX inventory purchases and to fuel the Company's growth in the mass market convenience store channel, it signed a very favorable $2 million credit facility with Michael D. King, one of the independent members of Charlie's Board of Directors.

  • The Company announced that it will open its first US manufacturing facility in Q4 2025 for filling of select product lines. In addition to mitigating shipping delays and tariff costs, the US-filled line will enable Charlie's to meet new domestic manufacturing requirements that have been announced by large states. The Company's new line will meet these new domestic manufacturing requirements and will appeal, broadly, to adult consumers who prefer "Made in America" products.

  • To prevent youth access to nicotine and non-nicotine vapor products, the Company has reported that it continues its efforts to develop age-gating technology for certain of its products in development.

Management Commentary

"Early SBX sales continue to exceed Company expectations… by a wide margin!" reported Ryan Stump, Charlie's Chief Operating Officer. "Already in Q4, we sold more SBX - $6 million worth during a two-day convenience store tradeshow - than we ever sold in an entire MONTH… In fact, our two days of show sales equate to 75% of what we sold in ALL OF 2024! Without question, SBX is greatly expanding Charlie's retail distribution in convenience stores that wish to carry flavored disposable vapes that are not in violation of the FDA's PMTA review process."

Henry Sicignano III, Charlie's President, explained, "If we had been able to finance and manufacture more product in Q3, we could have realized substantially more than $10 million in top line sales for the third quarter… and indeed, Q4 should eclipse this milestone." Mr. Sicignano continued, "With steady progress in the markets where SBX enjoys considerable competitive advantages, we believe $10 million in monthly sales, along with significantly improved net margins, could be achievable by mid-2026. Very exciting times for the Charlie's team… and for our shareholders."

Financial Results for the Three Months Ended September 30, 2025:

  • Revenue: For the three months ended September 30, 2025 revenue was $7.1 million, an increase of $5.5 million, or 336%, compared with $1.6 million for the three months ended September 30, 2024. The increase in revenue was primarily due to an increase in the sales of Charlie's (non-nicotine) SBX product line.

  • Gross Profit: For the three months ended September 30, 2025 gross profit was $1.8 million, an increase of $1.1 million, or 180%, compared with $0.86 million for the three months ended September 30, 2024. The resulting gross margin for the three months ended September 30, 2025 was 24.9%, compared with 38.8% for the three months ended September 30, 2024.

  • Total Operating Expenses: For the three months ended September 30, 2025, total operating expenses, including general and administrative, sales and marketing and research and development costs, were $2.1 million, an increase of $0.6 million, or 40%, compared with $1.5 million the three months ended September 30, 2024.

  • Net Income/Loss: For the three months ended September 30, 2025, net income was $0.6 million, compared with a net loss of $1.0 million for the three months ended September 30, 2024. Net income was negatively impacted by first-order product placement costs including displays, commissions, and promotional expenses, however the Company achieved an increase in net income for the quarter as a result of funds received from a strategic Buyer in the August 2025 PMTA asset sale.

About Charlie's Holdings, Inc.

Charlie's Holdings, Inc. (OTCQB:CHUC) is an industry leader in the premium vapor products space. The Company's products are sold around the world to select distributors, specialty retailers, and third-party online resellers through subsidiary company Charlie's Chalk Dust, LLC. Charlie's Chalk Dust has developed an extensive portfolio of brand styles, flavor profiles, and innovative product formats.

For additional information, please visit Charlie's corporate website at: Chuc.com and the Company's branded online websites: sbxvape.com, CharliesChalkDust.com, enjoypachamama.com, and Pacha.co.

Safe Harbor Statement

This press release contains "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to statements regarding the Company's overall business, existing and anticipated markets and expectations regarding future sales and expenses. Words such as "expect," "anticipate," "should," "believe," "target," "project," "goals," "estimate," "potential," "predict," "may," "will," "could," "intend," variations of these terms or the negative of these terms, and similar expressions, are intended to identify these forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond the Company's control. The Company's actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to: the Company's ongoing ability to quote its shares on the OTCQB; whether the Company will meet the requirements to up-list to a national securities exchange in the future; the Company's ability to successfully increase sales and enter new markets; whether the Company's PMTA's for its nicotine-containing products will be authorized by the FDA, and the FDA's decisions with respect to the Company's future PMTA's for nicotine products; the Company's ability to manufacture and produce products for its customers; the Company's ability to formulate new products; the acceptance of existing and future products; the complexity, expense and time associated with compliance with government rules and regulations affecting nicotine, synthetic nicotine, products containing nicotine substitutes, and products containing cannabidiol; litigation risks from the use of the Company's products; risks of government regulations; the impact of competitive products; and the Company's ability to maintain and enhance its brands, as well as other risk factors included in the Company's most recent quarterly report on Form 10-Q, annual report on Form 10-K, and other SEC filings. These forward-looking statements are made as of the date of this press release and are based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Except as required by law, the Company undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in its expectations.

Investors Contact:

IR@charliesholdings.com
Phone: 949-570-069

SOURCE: Charlie's Holdings, Inc.



View the original press release on ACCESS Newswire

FAQ

What were Charlie's Holdings (CHUC) Q3 2025 results?

CHUC reported Q3 2025 revenue of $7.1M (up 336% YoY) and net income of $0.6M for the quarter.

How significant is the SBX roll-out for CHUC and when did it begin?

The SBX Phase I roll-out began in Q3 2025 in 7 states; company says SBX now represents the majority of its sales.

What was the August 2025 PMTA asset sale for CHUC (symbol CHUC)?

On August 8, 2025 CHUC sold one PACHA PMTA asset for $1.0M, bringing total PMTA-related proceeds to $7.5M with $4.2M contingent.

When will Charlie's open its US manufacturing/filling line and why?

The company plans to open its first US filling facility in Q4 2025 to reduce shipping/tariffs and meet new domestic manufacturing requirements.

How did CHUC's profitability and margins change in Q3 2025?

CHUC moved to net income $0.6M in Q3 2025, while gross margin fell to 24.9% from 38.8% a year earlier.

Does Charlie's have additional financing to support SBX growth (CHUC)?

CHUC signed a $2M credit facility with a board member on August 26, 2025 to fund increased SBX inventory and mass-market rollout.
Charlie S Holdin

OTC:CHUC

CHUC Rankings

CHUC Latest News

CHUC Latest SEC Filings

CHUC Stock Data

83.56M
103.96M
60.39%
4.6%
Tobacco
Consumer Defensive
Link
United States
Costa Mesa